Myeloma Proteins and the Clinical Response to Melphalan Therapy

Science  16 Apr 1965:
Vol. 148, Issue 3668, pp. 376-377
DOI: 10.1126/science.148.3668.376


Objective improvement after therapy with melphalan occurred in all patients producing only Bence Jones kappa proteins, in half of the patients with myeloma serum proteins, and in none of those producing only Bence Jones lambda proteins.